Huanming Chen is the founder of Zhimeng Biopharma. Zhimeng Biopharma has raised $104M in total funding. Latest round: Series B. Based in Shanghai, China.
Huanming Chen is the Co-founder, President, and Chief Executive Officer of Zhimeng Biopharma, a medicines' developer established in 2017 in Shanghai, China, focusing on chronic hepatitis B. The company raised CNY 350 million in Series B funding in November 2021. Prior to co-founding Zhimeng Biopharma, Dr. Chen served as Vice President of Chemistry at Medicilon, Inc. and Head of Shanghai R&D Center at Simcere, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library